Elicera Therapeutics AB (publ) (STO:ELIC)
2.465
+0.025 (1.02%)
Nov 20, 2026, 5:25 PM CET
| Market Cap | 164.51M -35.6% |
| Revenue (ttm) | 7.79M +29.5% |
| Net Income | -17.98M |
| EPS | -0.36 |
| Shares Out | 66.74M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 81,375 |
| Open | 2.400 |
| Previous Close | 2.440 |
| Day's Range | 2.400 - 2.470 |
| 52-Week Range | 2.245 - 7.000 |
| Beta | 0.12 |
| Analysts | n/a |
| Price Target | 7.30 (+196.15%) |
| Earnings Date | Nov 27, 2026 |